Neuropeptide Y

[Guest guest]

Excerpted from CFIDS Association of America newsletter:

 

Researchers at University of Miami and University of Alberta published data

comparing levels of neuropeptide Y (NPY) in plasma samples taken from 93 CFS

patients, 100 healthy sedentary controls and 37 individuals with Gulf War

Illness. NPY levels in CFS patients were higher than in either control group.

Levels also correlated with some symptom severity measures, providing the

potential for NPY to be used as a biomarker for CFS. The authors state that this

data added to other information supports dysregulation of the

hypothalamic-pituitary-adrenal axis in CFS, possibly due to infection. This

study was funded in part by the CFIDS Association through a grant made in 2006.

(Behavioral and Brain Functions)

This is one of the biomarkers Bill mentioned that Dr Klimas's group has been

working on.

Sure would love to get a copy of that study .... anyone seen it?

Thanks,